CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 204 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03386994
NCT03386994N/ACompleted
CompareCT.gov

Observational Analysis on the Socio-economic Impact of IPF in Spain

Boehringer Ingelheim·observational·Posted Dec 29, 2017·Updated Nov 9, 2020

In Brief

An observational study for Idiopathic Pulmonary Fibrosis. Completed, enrolled 204 participants across 31 sites.

Detailed Summary

Descriptive prospective non-interventional multicenter study based on newly collected data of Idiopathic Pulmonary Fibrosis patients followed-up for one year in secondary care settings (Pulmonology Services)

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIdiopathic Pulmonary Fibrosis
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 29, 2017
Enrollment StartNov 29, 2017
Primary CompletionSep 16, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.5 years ago